About Cognivia
Cognivia is a company based in Mont-saint-guibert (Belgium) founded in 2013.. Cognivia has raised $16.5 million across 1 funding round from investors including Vesalius Biocapital Partners, SFPIM International and Wallonie Entreprendre. The company has 16 employees as of December 31, 2022. Cognivia offers products and services including Placebell and Compl-AI. Cognivia operates in a competitive market with competitors including Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Yunu, among others.
- Headquarter Mont-saint-guibert, Belgium
- Employees 16 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tools4patient Sa
-
Annual Revenue
-
Net Profit
$-1.28 M (USD)6as on Dec 31, 2022
-
EBITDA
$-374.99 K (USD)16as on Dec 31, 2022
-
Total Equity Funding
$16.5 M (USD)
in 1 rounds
-
Latest Funding Round
$16.5 M (USD), Series B
Apr 18, 2024
-
Investors
Vesalius Biocapital Partners
& 2 more
-
Employee Count
16
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cognivia
Cognivia offers a comprehensive portfolio of products and services, including Placebell and Compl-AI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reduces placebo response and data variability in clinical trials.
Predicts nonadherence and dropout risks to improve patient engagement.
Funding Insights of Cognivia
Cognivia has successfully raised a total of $16.5M through 1 strategic funding round. The most recent funding activity was a Series B round of $16.5 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $16.5M
-
First Round
First Round
(18 Apr 2024)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series B - Cognivia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cognivia
Cognivia has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Vesalius Biocapital Partners, SFPIM International and Wallonie Entreprendre. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SFPIM International is engaged in co-financing Belgian companies abroad.
|
Founded Year | Domain | Location | |
|
Life sciences-focused VC firm investing in Europe and Canada
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cognivia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cognivia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cognivia Comparisons
Competitors of Cognivia
Cognivia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Yunu, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CRO focused on providing clinical trial supply services for biopharma sector
|
|
| domain | founded_year | HQ Location |
Direct-to-patient clinical trial solutions are provided by Lightship.
|
|
| domain | founded_year | HQ Location |
Specialty pharmaceutical company based on partnering model
|
|
| domain | founded_year | HQ Location |
Clinical trial services are provided to support medical research initiatives.
|
|
| domain | founded_year | HQ Location |
Clinical trial imaging workflow and data management technology is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cognivia
Frequently Asked Questions about Cognivia
When was Cognivia founded?
Cognivia was founded in 2013 and raised its 1st funding round 11 years after it was founded.
Where is Cognivia located?
Cognivia is headquartered in Mont-saint-guibert, Belgium.
Who is the current CEO of Cognivia?
Dominique Demolle is the current CEO of Cognivia.
Is Cognivia a funded company?
Cognivia is a funded company, having raised a total of $16.5M across 1 funding round to date. The company's 1st funding round was a Series B of $16.5M, raised on Apr 18, 2024.
How many employees does Cognivia have?
As of Dec 31, 2022, the latest employee count at Cognivia is 16.
What does Cognivia do?
Founded in 2013 and based in Mont Saint Guibert, Belgium, Cognivia operates in the health technology sector. Data modeling solutions are developed to predict patient behavior and drug responses, addressing variability from placebo effects and patient heterogeneity. Tools for forecasting nonadherence and dropout risks are also offered, supporting patient engagement and enhancing study power for clinical development decisions.
Who are the top competitors of Cognivia?
Cognivia's top competitors include Lightship, SFJ Pharmaceuticals and N-Power Medicine.
What products or services does Cognivia offer?
Cognivia offers Placebell and Compl-AI.
Who are Cognivia's investors?
Cognivia has 3 investors. Key investors include Vesalius Biocapital Partners, SFPIM International, and Wallonie Entreprendre.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.